Print

IGPA organizes its 16 Annual Conference in Brussels

Brussels, 10 December 2013. The International Generic Pharmaceutical Alliance (IGPA) hosted its 16th Annual Conference “A Global Market - A Global Industry”. This event brought together more than 200 representatives from the pharmaceutical industry worldwide, European institutions, national authorities, and high level representatives from the IGPA. Addressing the audience, Laurette Onkelinx, Belgian Deputy Prime Minister and Minister of Social Affairs and Public Health, stressed the invaluable contribution of generic medicines to society stating that the generic medicines sector is a “sustainable industry that can invest in quality”.

Print

IGPA Letter Regarding TGA Guidance titled “Evaluation of Biosimilars”

In an era when increasing demands are being made on the world’s healthcare services, generic medicines provide a major benefit to society by ensuring patient access to quality, safe and effective medicines while reducing the cost of pharmaceutical care. The International Generic Pharmaceutical Alliance (IGPA) was born as an international network of generic medicines associations, committed to promoting generic medicines and exchanging information worldwide.

Print

IGPA Statement on the Trans-Pacific Partnership (TPP) Negotiations

The Asia-Pacific Region is of key importance to the generic pharmaceutical industry. It is the location of hundreds of generic manufacturing facilities and strategic export opportunities.  It is also an important source of pharmaceutical ingredients and other raw material inputs for our high-quality, low-cost medicines. As such, IGPA strongly supports efforts to expand trade in the region through the Trans-Pacific Partnership (TPP) negotiations.

Contact Info

IGBA | INTERNATIONAL GENERIC AND BIOSIMILAR MEDICINES ASSOCIATION

Rue d'Arlon, 50
B-1000 Brussels, Belgium

Telephone: +32 (0)2 736 84 11
Fax: +32 (0)2 736 74 38
E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.